LunaDNA share value of a whole genome against consumer genotyping data
300 shares and 50 shares
ratio of shares allocated, whole genome to genotyping data, US
““Generally speaking, the richer the data, the more shares are allocated to that data.’’ The genotyping data a customer gets from 23andMe, for example, would be worth 50 shares, while a whole genome would equal 300 shares”
ThinkAdvisor, Share your DNA, get shares (5 October 2018; read from an Internet Archive copy), 2018-10
- Kind of source
- Named press report
- Read on
- 2026-11-06
- Daily check
- Source re-read on 2026-11-06 needs a browser (PDF or protected page)
- What to know
- Company allocation rule from its offering, not a market price: richer data earns more shares.
- Arithmetic
- 300 shares / 50 shares = 6.
Used in
Kept as evidence; no figure on the platform is computed from it yet.